The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.

Video on Dry Eyeeye_pic.jpg

In recent years the nosology of Dry Eye has greatly changed. Professor Baudouin, MD, PhD from National Ophthalmologiy Hospital XV-XX, Vision Institute of Paris explains through this didactic video the complexity of the Dry Eye disease. Moving beyond the simple name of Dry Eye syndrome, we now consider the condition to be Dry Eye disease, insisting on the lack of tears, the lacrimal inflammation and hyperevaporation leading to self-sustaining loops of neurogenic and palpebral inflammations.

View the video

The therapy of choice in dry eye

VISMED® is a unique preservative-free lubricant eye drop that offers an unmatched combination of long-lasting relief of sensations of ocular dryness with optimal eye comfort.

VISMED® is compatible with all types of contact lenses (rigid or soft) during wear.

VISMED® is a patented hypotonic formulation that contains both 0.18% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.

VISMED® is available in boxes of 20 (or 60) single dose units of 0.3 ml

pdf VISMED® leaflet
pdf VISMED® range brochure
flv_small.gif VISMED® range video
trb_lock.gif Doctor information

  • English